Epilepsy is categorized as a chronic disease of the brain and continues to affect millions of individuals worldwide. Although the prevalence of epilepsy is marginally higher in men compared to women, it affects individuals from all age groups. The prevalence of focal seizures is higher than that of generalized seizures in both, children as well as adults. The prevalence of epileptic seizures is higher in low to middle-income countries due to which, the demand for epileptic seizure treatment is high from developing regions. Some of the major factors responsible for the high prevalence of epileptic seizures in developing regions include acute symptomatic seizures, misdiagnosis, and lack of advanced medical infrastructure.
As epilepsy continues to emerge as a critical cause of mortality and disability around the world, considerable attention has been given to the development and discovery of new epileptic seizures treatment– a factor that is expected to drive the epileptic seizures treatment market during the forecast period. At present, players involved in the current epileptic seizures treatment market are increasingly focusing on reducing the burden of epileptic seizures, improving the access to the existing epileptic seizures treatments, and development of new vaccines and drugs particularly in the low/middle-income countries.
At the back of these factors, along with considerable rise in the number of research and development activities, the global epileptic seizures treatment market is on course to surpass the US$ 1.8 Bn mark by the end of 2030.
Over the past few decades, apart from conventional strategies deployed to treat epileptic seizures, including medicine and surgery, a number of alternative treatment options such as deep brain stimulation, vague nerve stimulation, and adoption of ketogenic diet have emerged. As the focus on providing a seizure-free life continues to remain high, considerable improvements have been made in epilepsy diagnosis and treatment. For instance, a range of wearable seizure detectors have been developed that play a key role in tracking the seizure activities of individuals. These devices are likely to minimize unexpected deaths caused by uncontrolled seizures and thereby, increase the demand for epileptic seizures treatment.
Due to the increasing demand for minimally invasive surgeries, a number of new treatment alternatives have gained considerable momentum in recent years. For instance, stereotactic radiosurgery has gradually gained considerable spotlight as a feasible, effective, and an ideal minimally invasive epileptic seizures treatment– a factor that will continue to drive the growth of the global epileptic seizures treatment market in the upcoming years. Furthermore, MRI-guided laser ablation is another treatment alternative that is expected to gain noteworthy adoption in the upcoming years and provide a considerable boost to the growth of the market for epileptic seizures treatment.
While advancements at the surgical front are expected to remain steady throughout the forecast period, considerable progress has been made in the drug-based treatment sphere. A number of researchers and medical experts is increasingly collaborating with each other to improve the current state of epileptic seizures treatment– a factor that is likely to boost market growth.
The advent of the novel COVID-19 pandemic is projected to have a low impact on the overall growth of the global epileptic seizures treatment market in 2020. Research and development activities in the epileptic seizures treatment market continue to explore the potential risk of contracting the COVID-19 infection among epileptic patients. Some research findings suggest that epileptic patients are at a higher risk of contracting the novel coronavirus disease due to which, the demand for telemedicine services continues to grow within the epileptic seizures treatment market. The increasing demand for telemedicine epileptic seizures treatment during the ongoing pandemic is projected to provide a considerable boost to the growth of the global epileptic seizures treatment market in 2020.
Analysts’ Viewpoint
The global epileptic seizures treatment market is expected to grow at a moderate CAGR of ~4% during the forecast period. Increasing prevalence of epileptic seizures in patients worldwide, focus on providing a seizure-free life to patients, entry of a number of seizure detection devices, advancements in technology, and focus on research and development. Market players should focus on improving the efficacy of existing treatments and improving the accessibility to current epileptic seizures treatments particularly in developing regions.
Epileptic Seizures Treatment Market – Segmentation
TMR’s study on the global epileptic seizures treatment market includes information divided into four sections: therapeutic, type, route of administration, distribution channel, and region. Changing industry trends and other crucial market dynamics associated with these sections of the global epileptic seizures treatment market have been discussed in detail.
|
Therapeutic |
|
|
Type |
|
|
Route of Administration |
|
|
Distribution Channel |
|
|
Region |
|
Epileptic seizures treatment market to reach Valuation Of US$ 1.8 Bn By 2030
Epileptic seizures treatment market is projected to expand at a CAGR of ~4% from 2020 to 2030
Epileptic seizures treatment market is driven by increase in patient population with status epilepticus and acute repetitive seizures
North America accounted for a major share of the global epileptic seizures treatment market, owing to rise in prevalence of neurological disorders
Key players in the global epileptic seizures treatment market include Bausch Health Companies, Inc., GlaxoSmithKline plc., UCB S.A., Pfizer, Inc., Apotex, Inc., Alexza Pharmaceuticals, Inc.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Epileptic Seizures Treatment Market
4. Market Overview
4.1. Introduction
4.1.1. Market Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Epileptic Seizures Treatment Market Analysis and Forecast, 2018–2030
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Pipeline Analysis
5.2. Disease Prevalence & Incidence Rate globally with key countries
5.3. Key Industry Events (mergers, acquisitions, collaborations, partnerships, etc.)
5.4. COVID-19 Pandemic Impact on Industry (Value Chain and Short / Mid / Long Term Impact)
6. Global Epileptic Seizures Treatment Market Analysis and Forecast, by Therapeutics
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Therapeutics, 2018–2030
6.3.1. Midazolam
6.3.2. Alprazolam
6.3.3. Diazepam
6.3.4. Lorazepam
6.3.5. Phenytoin
6.3.6. Fosphenytoin
6.3.7. Others
6.4. Market Attractiveness Analysis, by Therapeutics
7. Global Epileptic Seizures Treatment Market Analysis and Forecast, by Type
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Type, 2018–2030
7.3.1. Repetitive Seizures
7.3.2. Status Epilepticus
7.3.2.1. Convulsive Status Epilepticus
7.3.2.2. Non-convulsive Status Epilepticus
7.3.3. Others
7.4. Market Attractiveness Analysis, by Type
8. Global Epileptic Seizures Treatment Market Analysis and Forecast, by Route of Administration
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Route of Administration, 2018–2030
8.3.1. Oral/Buccal
8.3.2. Rectal
8.3.3. Nasal
8.3.4. Parenteral
8.4. Market Attractiveness Analysis, by Route of Administration
9. Global Epileptic Seizures Treatment Market Analysis and Forecast, by Distribution Channel
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Market Value Forecast, by Distribution Channel, 2018–2030
9.3.1. Hospital Pharmacies
9.3.2. Retail Pharmacies
9.3.3. Online Pharmacies
9.4. Market Attractiveness Analysis, by Distribution Channel
10. Global Epileptic Seizures Treatment Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Market Value Forecast, by Region
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness Analysis, by Country/Region
11. North America Epileptic Seizures Treatment Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Therapeutics, 2018–2030
11.2.1. Midazolam
11.2.2. Alprazolam
11.2.3. Diazepam
11.2.4. Lorazepam
11.2.5. Phenytoin
11.2.6. Fosphenytoin
11.2.7. Others
11.3. Market Value Forecast, by Type, 2018–2030
11.3.1. Repetitive Seizures
11.3.2. Status Epilepticus
11.3.2.1. Convulsive Status Epilepticus
11.3.2.2. Non-convulsive Status Epilepticus
11.3.3. Others
11.4. Market Value Forecast, by Route of Administration, 2018–2030
11.4.1. Oral/Buccal
11.4.2. Rectal
11.4.3. Nasal
11.4.4. Parenteral
11.5. Market Value Forecast, by Distribution Channel, 2018–2030
11.5.1. Hospital Pharmacies
11.5.2. Retail Pharmacies
11.5.3. Online Pharmacies
11.6. Market Value Forecast, by Country, 2018–2030
11.6.1. U.S.
11.6.2. Canada
11.7. Market Attractiveness Analysis
11.7.1. By Therapeutics
11.7.2. By Type
11.7.3. By Route of Administration
11.7.4. By Distribution Channel
11.7.5. By Country
12. Europe Epileptic Seizures Treatment Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Therapeutics, 2018–2030
12.2.1. Midazolam
12.2.2. Alprazolam
12.2.3. Diazepam
12.2.4. Lorazepam
12.2.5. Phenytoin
12.2.6. Fosphenytoin
12.2.7. Others
12.3. Market Value Forecast, by Type, 2018–2030
12.3.1. Repetitive Seizures
12.3.2. Status Epilepticus
12.3.2.1. Convulsive Status Epilepticus
12.3.2.2. Non-convulsive Status Epilepticus
12.3.3. Others
12.4. Market Value Forecast, by Route of Administration, 2018–2030
12.4.1. Oral/Buccal
12.4.2. Rectal
12.4.3. Nasal
12.4.4. Parenteral
12.5. Market Value Forecast, by Distribution Channel, 2018–2030
12.5.1. Hospital Pharmacies
12.5.2. Retail Pharmacies
12.5.3. Online Pharmacies
12.6. Market Value Forecast, by Country/Sub-region, 2018–2030
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Spain
12.6.5. Italy
12.6.6. Rest of Europe
12.7. Market Attractiveness Analysis
12.7.1. By Therapeutics
12.7.2. By Type
12.7.3. By Route of Administration
12.7.4. By Distribution Channel
12.7.5. By Country/Sub-region
13. Asia Pacific Epileptic Seizures Treatment Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Therapeutics, 2018–2030
13.2.1. Midazolam
13.2.2. Alprazolam
13.2.3. Diazepam
13.2.4. Lorazepam
13.2.5. Phenytoin
13.2.6. Fosphenytoin
13.2.7. Others
13.3. Market Value Forecast, by Type, 2018–2030
13.3.1. Repetitive Seizures
13.3.2. Status Epilepticus
13.3.2.1. Convulsive Status Epilepticus
13.3.2.2. Non-convulsive Status Epilepticus
13.3.3. Others
13.4. Market Value Forecast, by Route of Administration, 2018–2030
13.4.1. Oral/Buccal
13.4.2. Rectal
13.4.3. Nasal
13.4.4. Parenteral
13.5. Market Value Forecast, by Distribution Channel, 2018–2030
13.5.1. Hospital Pharmacies
13.5.2. Retail Pharmacies
13.5.3. Online Pharmacies
13.6. Market Value Forecast, by Country/Sub-region, 2018–2030
13.6.1. China
13.6.2. Japan
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7. Market Attractiveness Analysis
13.7.1. By Therapeutics
13.7.2. By Type
13.7.3. By Route of Administration
13.7.4. By Distribution Channel
13.7.5. By Country/Sub-region
14. Latin America Epileptic Seizures Treatment Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Therapeutics, 2018–2030
14.2.1. Midazolam
14.2.2. Alprazolam
14.2.3. Diazepam
14.2.4. Lorazepam
14.2.5. Phenytoin
14.2.6. Fosphenytoin
14.2.7. Others
14.3. Market Value Forecast, by Type, 2018–2030
14.3.1. Repetitive Seizures
14.3.2. Status Epilepticus
14.3.2.1. Convulsive Status Epilepticus
14.3.2.2. Non-convulsive Status Epilepticus
14.3.3. Others
14.4. Market Value Forecast, by Route of Administration, 2018–2030
14.4.1. Oral/Buccal
14.4.2. Rectal
14.4.3. Nasal
14.4.4. Parenteral
14.5. Market Value Forecast, by Distribution Channel, 2018–2030
14.5.1. Hospital Pharmacies
14.5.2. Retail Pharmacies
14.5.3. Online Pharmacies
14.6. Market Value Forecast, by Country/Sub-region, 2018–2030
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Market Attractiveness Analysis
14.7.1. By Therapeutics
14.7.2. By Type
14.7.3. By Route of Administration
14.7.4. By Distribution Channel
14.7.5. By Country/Sub-region
15. Middle East & Africa Epileptic Seizures Treatment Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Therapeutics, 2018–2030
15.2.1. Midazolam
15.2.2. Alprazolam
15.2.3. Diazepam
15.2.4. Lorazepam
15.2.5. Phenytoin
15.2.6. Fosphenytoin
15.2.7. Others
15.3. Market Value Forecast, by Type, 2018–2030
15.3.1. Repetitive Seizures
15.3.2. Status Epilepticus
15.3.2.1. Convulsive Status Epilepticus
15.3.2.2. Non-convulsive Status Epilepticus
15.3.3. Others
15.4. Market Value Forecast, by Route of Administration, 2018–2030
15.4.1. Oral/Buccal
15.4.2. Rectal
15.4.3. Nasal
15.4.4. Parenteral
15.5. Market Value Forecast, by Distribution Channel, 2018–2030
15.5.1. Hospital Pharmacies
15.5.2. Retail Pharmacies
15.5.3. Online Pharmacies
15.6. Market Value Forecast, by Country/Sub-region, 2018–2030
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7. Market Attractiveness Analysis
15.7.1. By Therapeutics
15.7.2. By Type
15.7.3. By Route of Administration
15.7.4. By Distribution Channel
15.7.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player - Competition Matrix (by tier and size of companies)
16.2. Market Share/Position Analysis, by Company, 2019
16.3. Competitive Business Strategies
16.4. Company Profiles
16.4.1.Bausch Health Companies, Inc.
16.4.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.4.1.2. Company Financials
16.4.1.3. Growth Strategies
16.4.1.4. SWOT Analysis
16.4.2.GlaxoSmithKline plc.
16.4.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.4.2.2. Company Financials
16.4.2.3. Growth Strategies
16.4.2.4. SWOT Analysis
16.4.3.UCB S.A.
16.4.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.4.3.2. Company Financials
16.4.3.3. Growth Strategies
16.4.3.4. SWOT Analysis
16.4.4. Pfizer, Inc.
16.4.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.4.4.2. Company Financials
16.4.4.3. Growth Strategies
16.4.4.4. SWOT Analysis
16.4.5.Apotex, Inc.
16.4.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.4.5.2. Company Financials
16.4.5.3. Growth Strategies
16.4.5.4. SWOT Analysis
16.4.6.Alexza Pharmaceuticals, Inc.
16.4.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.4.6.2. Company Financials
16.4.6.3. Growth Strategies
16.4.6.4. SWOT Analysis
16.4.7. Neurelis, Inc.
16.4.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.4.7.2. Company Financials
16.4.7.3. Growth Strategies
16.4.7.4. SWOT Analysis
16.4.8.Veriton Pharma
16.4.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.4.8.2. Company Financials
16.4.8.3. Growth Strategies
16.4.8.4. SWOT Analysis
List of Tables
Table 01: Pipeline Analysis
Table 02: Global Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Therapeutics, 2018–2030
Table 03: Global Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Type, 2018–2030
Table 04: Global Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Status Epilepticus, 2018–2030
Table 05: Global Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030
Table 06: Global Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
Table 07: Global Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Region, 2018–2030
Table 08: North America Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Country, 2018–2030
Table 09: North America Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Therapeutics, 2018–2030
Table 10: North America Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Type, 2018–2030
Table 11: North America Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Status Epilepticus, 2018–2030
Table 12: North America Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030
Table 13: North America Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
Table 14: Europe Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 15: Europe Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Therapeutics, 2018–2030
Table 16: Europe Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Type, 2018–2030
Table 17: Europe Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Status Epilepticus, 2018–2030
Table 18: Europe Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030
Table 19: Europe Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
Table 20: Asia Pacific Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 21: Asia Pacific Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Therapeutics, 2018–2030
Table 22: Asia Pacific Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Type, 2018–2030
Table 23: Asia Pacific Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Status Epilepticus, 2018–2030
Table 24: Asia Pacific Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030
Table 25: Asia Pacific Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
Table 26: Latin America Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 27: Latin America Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Therapeutics, 2018–2030
Table 28: Latin America Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Type, 2018–2030
Table 29: Latin America Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Status Epilepticus, 2018–2030
Table 30: Latin America Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030
Table 31: Latin America Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
Table 32: Middle East & Africa Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 33: Middle East & Africa Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Therapeutics, 2018–2030
Table 34: Middle East & Africa Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Type, 2018–2030
Table 35: Middle East & Africa Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Status Epilepticus, 2018–2030
Table 36: Middle East & Africa Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030
Table 37: Middle East & Africa Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
List of Figures
Figure 01: Global Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, 2018–2030
Figure 02: Global Epileptic Seizures Treatment Market Value Share, by Therapeutics, 2019
Figure 03: Global Epileptic Seizures Treatment Market Value Share, by Type, 2019
Figure 04: Global Epileptic Seizures Treatment Market Value Share, by Route of Administration 2019
Figure 05: Global Epileptic Seizures Treatment Market Value Share, by Distribution Channel, 2019
Figure 06: Global Epileptic Seizures Treatment Market Value Share, by Region, 2019
Figure 07: Global Epileptic Seizures Treatment Market Value Share, by Status Epilepticus, 2019
Figure 08: Global Epileptic Seizures Treatment Market Value Share Analysis, by Therapeutics, 2019 and 2030
Figure 09: Global Epileptic Seizures Treatment Market Value (US$ Mn), by Midazolam, 2018–2030
Figure 10: Global Epileptic Seizures Treatment Market Value (US$ Mn), by Alprazolam, 2018–2030
Figure 11: Global Epileptic Seizures Treatment Market Value (US$ Mn), by Diazepam, 2018–2030
Figure 12: Global Epileptic Seizures Treatment Market Value (US$ Mn), by Lorazepam, 2018–2030
Figure 13: Global Epileptic Seizures Treatment Market Value (US$ Mn), by Phenytoin, 2018–2030
Figure 14: Global Epileptic Seizures Treatment Market Value (US$ Mn), by Fosphenytoin, 2018–2030
Figure 15: Global Epileptic Seizures Treatment Market Value (US$ Mn), by Others, 2018–2030
Figure 16: Global Epileptic Seizures Treatment Market Attractiveness Analysis, by Therapeutics, 2020–2030
Figure 17: Global Epileptic Seizures Treatment Market Value Share Analysis, by Type, 2019 and 2030
Figure 18: Global Epileptic Seizures Treatment Market Value (US$ Mn) and Y-o-Y Growth (%), by Repetitive Seizures, 2018-2030
Figure 19: Global Epileptic Seizures Treatment Market Value (US$ Mn) and Y-o-Y Growth (%), by Status Epilepticus, 2018-2030
Figure 20: Global Epileptic Seizures Treatment Market Value (US$ Mn), by Others, 2018–2030
Figure 21: Global Epileptic Seizures Treatment Market Attractiveness Analysis, by Type, 2020–2030
Figure 22: Global Epileptic Seizures Treatment Market Value Share Analysis, by Route of Administration, 2019 and 2030
Figure 23: Global Epileptic Seizures Treatment Market Value (US$ Mn), by Oral/Buccal, 2018–2030
Figure 24: Global Epileptic Seizures Treatment Market Value (US$ Mn), by Rectal, 2018–2030
Figure 25: Global Epileptic Seizures Treatment Market Value (US$ Mn), by Nasal, 2018–2030
Figure 26: Global Epileptic Seizures Treatment Market Value (US$ Mn), by Parenteral, 2018–2030
Figure 27: Global Epileptic Seizures Treatment Market Attractiveness Analysis, by Route of Administration, 2020–2030
Figure 28: Global Epileptic Seizures Treatment Market Value Share Analysis, by Distribution Channel, 2019 and 2030
Figure 29: Global Epileptic Seizures Treatment Market Value (US$ Mn) and Y-o-Y Growth (%), by Hospital Pharmacies, 2018-2030
Figure 30: Global Epileptic Seizures Treatment Market Value (US$ Mn) and Y-o-Y Growth (%), by Retail Pharmacies, 2018-2030
Figure 31: Global Epileptic Seizures Treatment Market Value (US$ Mn), by Online Pharmacies, 2018–2030
Figure 32: Global Epileptic Seizures Treatment Market Attractiveness Analysis, by Distribution Channel, 2020–2030
Figure 33: Global Epileptic Seizures Treatment Market Value Share Analysis, by Region, 2019 and 2030
Figure 34: Global Epileptic Seizures Treatment Market Attractiveness Analysis, by Region, 2020–2030
Figure 35: North America Epileptic Seizures Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030
Figure 36: North America Epileptic Seizures Treatment Market Value Share (%), by Country, 2019 and 2030
Figure 37: North America Epileptic Seizures Treatment Market Attractiveness Analysis, by Country, 2020–2030
Figure 38: North America Epileptic Seizures Treatment Market Value Share (%), by Therapeutics, 2019 and 2030
Figure 39: North America Epileptic Seizures Treatment Market Attractiveness Analysis, by Therapeutics, 2020–2030
Figure 40: North America Epileptic Seizures Treatment Market Value Share (%), by Type, 2019 and 2030
Figure 41: North America Epileptic Seizures Treatment Market Attractiveness Analysis, by Type, 2020–2030
Figure 42: North America Epileptic Seizures Treatment Market Value Share (%), by Route of Administration, 2019 and 2030
Figure 43: North America Epileptic Seizures Treatment Market Attractiveness Analysis, by Route of Administration, 2020–2030
Figure 44: North America Epileptic Seizures Treatment Market Value Share (%), by Distribution Channel, 2019 and 2030
Figure 45: North America Epileptic Seizures Treatment Market Attractiveness Analysis, by Distribution Channel, 2020–2030
Figure 46: Europe Epileptic Seizures Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030
Figure 47: Europe Epileptic Seizures Treatment Market Value Share (%), by Country/Sub-region, 2019 and 2030
Figure 48: Europe Epileptic Seizures Treatment Market Attractiveness Analysis, by Country/Sub-region, 2020–2030
Figure 49: Europe Epileptic Seizures Treatment Market Value Share (%), by Therapeutics, 2019 and 2030
Figure 50: Europe Epileptic Seizures Treatment Market Attractiveness Analysis, by Therapeutics, 2020–2030
Figure 51: Europe Epileptic Seizures Treatment Market Value Share (%), by Type, 2019 and 2030
Figure 52: Europe Epileptic Seizures Treatment Market Attractiveness Analysis, by Type, 2020–2030
Figure 53: Europe Epileptic Seizures Treatment Market Value Share (%), by Route of Administration, 2019 and 2030
Figure 54: Europe Epileptic Seizures Treatment Market Attractiveness Analysis, by Route of Administration, 2020–2030
Figure 55: Europe Epileptic Seizures Treatment Market Value Share (%), by Distribution Channel, 2019 and 2030
Figure 56: Europe Epileptic Seizures Treatment Market Attractiveness Analysis, by Distribution Channel, 2020–2030
Figure 57: Asia Pacific Epileptic Seizures Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030
Figure 58: Asia Pacific Epileptic Seizures Treatment Market Value Share (%), by Country/Sub-region, 2019 and 2030
Figure 59: Asia Pacific Epileptic Seizures Treatment Market Attractiveness Analysis, by Country/Sub-region, 2020–2030
Figure 60: Asia Pacific Epileptic Seizures Treatment Market Value Share (%), by Therapeutics, 2019 and 2030
Figure 61: Asia Pacific Epileptic Seizures Treatment Market Attractiveness Analysis, by Therapeutics, 2020–2030
Figure 62: Asia Pacific Epileptic Seizures Treatment Market Value Share (%), by Type, 2019 and 2030
Figure 63: Asia Pacific Epileptic Seizures Treatment Market Attractiveness Analysis, by Type, 2020–2030
Figure 64: Asia Pacific Epileptic Seizures Treatment Market Value Share (%), by Route of Administration, 2019 and 2030
Figure 65: Asia Pacific Epileptic Seizures Treatment Market Attractiveness Analysis, by Route of Administration, 2020–2030
Figure 66: Asia Pacific Epileptic Seizures Treatment Market Value Share (%), by Distribution Channel, 2019 and 2030
Figure 67: Asia Pacific Epileptic Seizures Treatment Market Attractiveness Analysis, by Distribution Channel, 2020–2030
Figure 68: Latin America Epileptic Seizures Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030
Figure 69: Latin America Epileptic Seizures Treatment Market Value Share (%), by Country/Sub-region, 2019 and 2030
Figure 70: Latin America Epileptic Seizures Treatment Market Attractiveness Analysis, by Country/Sub-region, 2020–2030
Figure 71: Latin America Epileptic Seizures Treatment Market Value Share (%), by Therapeutics, 2019 and 2030
Figure 72: Latin America Epileptic Seizures Treatment Market Attractiveness Analysis, by Therapeutics, 2020–2030
Figure 73: Latin America Epileptic Seizures Treatment Market Value Share (%), by Type, 2019 and 2030
Figure 74: Latin America Epileptic Seizures Treatment Market Attractiveness Analysis, by Type, 2020–2030
Figure 75: Latin America Epileptic Seizures Treatment Market Value Share (%), by Route of Administration, 2019 and 2030
Figure 76: Latin America Epileptic Seizures Treatment Market Attractiveness Analysis, by Route of Administration, 2020–2030
Figure 77: Latin America Epileptic Seizures Treatment Market Value Share (%), by Distribution Channel, 2019 and 2030
Figure 78: Latin America Epileptic Seizures Treatment Market Attractiveness Analysis, by Distribution Channel, 2020–2030
Figure 79: Middle East & Africa Epileptic Seizures Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030
Figure 80: Middle East & Africa Epileptic Seizures Treatment Market Value Share (%), by Country/Sub-region, 2019 and 2030
Figure 81: Middle East & Africa Epileptic Seizures Treatment Market Attractiveness Analysis, by Country/Sub-region, 2020–2030
Figure 82: Middle East & Africa Epileptic Seizures Treatment Market Value Share (%), by Therapeutics, 2019 and 2030
Figure 83: Middle East & Africa Epileptic Seizures Treatment Market Attractiveness Analysis, by Therapeutics, 2020–2030
Figure 84: Middle East & Africa Epileptic Seizures Treatment Market Value Share (%), by Type, 2019 and 2030
Figure 85: Middle East & Africa Epileptic Seizures Treatment Market Attractiveness Analysis, by Type, 2020–2030
Figure 86: Middle East & Africa Epileptic Seizures Treatment Market Value Share (%), by Route of Administration, 2019 and 2030
Figure 87: Middle East & Africa Epileptic Seizures Treatment Market Attractiveness Analysis, by Route of Administration, 2020–2030
Figure 88: Middle East & Africa Epileptic Seizures Treatment Market Value Share (%), by Distribution Channel, 2019 and 2030
Figure 89: Middle East & Africa Epileptic Seizures Treatment Market Attractiveness Analysis, by Distribution Channel, 2020–2030
Figure 90: Market Position/Ranking Analysis, 2019, by Tier and Size of the Company
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Epileptic Seizures Treatment Market
